Appetitt og matinntak Hva bør vi spise og hvordan får vi det til?



Similar documents
ESPEN Congress Brussels 2005

Dietary Composition for Weight Loss and Weight Loss Maintenance

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

New Nordic Diet - principles, development and health potential

Know Your Resistance A Guide to Better Health

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011

Effects of macronutrients on insulin resistance and insulin requirements

The CSIRO Total Wellbeing Diet -from lab bench to kitchen bench. Manny Noakes CSIRO Food and Nutritional Sciences

The South Asian Indian Women s s Weight Loss Study. Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

The Glycemic Index. Professor, Pediatrics, Harvard Medical School Professor, Nutrition, Harvard School of Public Health

Myth vs. Reality: Diabetes Related

Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology

Participant Guide Adopt a healthy lifestyle: prevent or better manage type 2 diabetes

Statins and Risk for Diabetes Mellitus. Background

Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

Cardiac Rehabilitation

The Obesity Explosion: How Did We Get Here and Where Are We At?

A program presented by... WellStar Health System Diabetes Education. Lisa Mason, MS,RD,LD,CDE

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

Freiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.

CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE

Cardiovascular Disease Risk Factors

The Skinny on Visceral Fat

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

Blood clot in atheroma. help make vitamin D and hormones, like oestrogen and testosterone, in your body.

Technology Assessment

How To Lose Weight With Diabetes

Insulin Receptor Substrate 1 (IRS1) Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in A Two-year Randomized Trial

Margarines and Heart Disease. Do they protect?

High Blood Cholesterol What you need to know

Chapter 5 DASH Your Way to Weight Loss

Nonalcoholic Fatty Liver Disease. Dietary and Lifestyle Guidelines

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status?

Fundamentals of Diabetes Care Module 3, Lesson 1

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Adult Weight Management Training Summary

Is Insulin Effecting Your Weight Loss and Your Health?

YOUR LAST DIET IDEAL PROTEIN

Do You Know the Health Risks of Being Overweight?

What is a Heart Attack? 1,2,3

Dealing with weight regain after Rouxen-Y gastric bypass: surgical approach

Triglycerides: Frequently Asked Questions

Technical Aspects of Bariatric Surgical Procedures. Robert O. Carpenter, MD, MPH, FACS Department of Surgery Scott & White Memorial Hospital

Diabetes and Obesity. The diabesity epidemic

Diabetes and Heart Disease

Facts About Peripheral Arterial Disease (P.A.D.)

Weight Loss Surgery and Bariatric Nutrition. Jeanine Giordano, MS, RD, CDN

Surgical Weight Loss. Mission Bariatrics

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Causes, incidence, and risk factors

HEALTH CLAIMS ON PECTINS APPROVED BY EFSA

Beating insulin resistance through lifestyle changes

This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.

MY TYPE 2 DIABETES NUMBERS

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

Health Maintenance: Controlling Cholesterol

CHOLESTEROL 101: WHAT YOU NEED TO KNOW TO KEEP YOUR HEART HEALTHY. By: Camille Quiles, PharmD., RPh.

2) Herewith the 2nd question in our Q&A series with Ria Catsicas about 'Nutrition and Diabetes':

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

Diabetes and Aboriginal Canadians

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

7 Ways Your DNA Influences Your Ability to Lose Weight

9 TH GRADE KINETIC WELLNESS

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

How To Know If Low Protein Diet Is Beneficial For Kidney Health

Dietary Fiber and Alcohol. Nana Gletsu Miller, PhD Spring 2014

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

How To Treat Dyslipidemia

CARDIAC REHABILITATION Winnipeg Region Annual Report

Heart Healthy Living

Daily Diabetes Management Book

BEST & WORST FOODS FOR BELLY FAT

High Blood Pressure in People with Diabetes:

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

You may continue to use your old manuals by writing in the detailed changes below:

Main Effect of Screening for Coronary Artery Disease Using CT

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

An Interview with Gerald Reaven: Syndrome X : The Risks of Insulin Resistance

How To Get Healthy

The Need for an Integrative Approach to Pediatric Obesity

Transcription:

Institut for Idræt og Ernæring Appetitt og matinntak Hva bør vi spise og hvordan får vi det til? Arne Astrup Professor, overlæge, dr.med. Leder af Institut for Idræt og Ernæring, KU & Klinisk Ernæring, Herlev Universitets Hospital 19-09-2013 Dias 1

19-09-2013 Dias 2 Institut for Idræt og Ernæring

19-09-2013 Dias 3 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring The Atkin s type of lowcarb diets are extreme, and not consistent with a balanced food culture The elimination of important food groups leeds to poor adherence in the long-term and adverse effects due to carbohydrate deficiency = headache, muscle cramps, low physical performance 19-09-2013 Dias 4

19-09-2013 Dias 5 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring The GI concept as a weight loss strategy? 19-09-2013 Dias 6 New York Times Bestseller Released January 2005

Institut for Idræt og Ernæring 40% 100% Glucose load 19-09-2013 Dias 7 Time Stomach and small intestine, showing (A) slow absorption of energydilute nutrient in a fibre-rich primitive diet, and (B) rapid absorption of energy-dense nutrient from low-fibre, modern Western foods.

19-09-2013 Dias 8 Institut for Idræt og Ernæring

19-09-2013 Dias 9 Institut for Idræt og Ernæring

19-09-2013 Dias 10 Institut for Idræt og Ernæring

19-09-2013 Dias 11 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring RCT on Type 2 diabetes 19-09-2013 Dias 12

19-09-2013 Dias 13 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring Cochrane Review - MAIN RESULTS: We identified six eligible randomised controlled trials (total of 202 participants). Interventions ranged from five weeks to six months duration with up to six months follow-up after the intervention ceased. LGI decreased body mass (WMD -1.1 kg, 95% confidence interval (CI) -2.0 to -0.2, P < 0.05) (n = 163) LGI decreased total fat mass (WMD -1.1 kg, 95% CI -1.9 to -0.4, P < 0.05) (n =147) LGI decrease total cholesterol (WMD -0.22 mmol/l, 95% CI -0.43 to -0.02, P < 0.05) LGI decreased LDL-cholesterol (WMD -0.24 mmol/l, 95% CI -0.44 to -0.05, P < 0.05). No study reported adverse effects, mortality or quality of life data. 19-09-2013 Dias 14

Proposed Hierarchy of Satiety Need hypothesis-driven studies to determine differences Protein leucine LOW Glycemic Index Whole grain HIGH Glycemic Index Carbohydrate Sucrose/Fructose Fat

19-09-2013 Dias 16 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring Glucose and insulin responses 19-09-2013 Dias 17

4-h VAS Satiety (mm) Institut for Idræt og Ernæring Replacement of carbohydrate for protein increases satiety in a dosedependent manner 70 HP MHP NP 60 50 40 30 20 10 0 0 30 60 90 120 150 180 210 240 Time (minutes) NP vs HP: 16%, P<0.0001 MHP: 7%, P=0.001 HP vs MHP: 10%, P<0.0001 19-09-2013 Dias 18

GLP-1 (pm) Institut for Idræt og Ernæring 4-h dose-dependent effect on GLP-1 50 HP M HP NP 40 30 20 10 0-10 0 30 60 90 120 150 180 210 240-20 Time (minutes) NP vs. HP: 25%, P<0.0001 MHP: 9%, P=0.02 HP vs MHP: 14%, P=0.002 19-09-2013 Dias 19

PYY (pm) Institut for Idræt og Ernæring 4-h dose-dependent effect on PYY 40 HP M HP NP 35 30 25 20 15 10 5 0 0 30 60 90 120 150 180 210 240 Time (minutes) NP vs HP: 14%, P<0.0001 MHP: 7%, P=0.0002 HP vs MHP: 7%, P<0.0001 19-09-2013 Dias 20

19-09-2013 Dias 21 Institut for Idræt og Ernæring

Contract no. FP6-2005-513946 The Diogenes project A pan-european programme targeting the obesity problem www.diogenes-eu.org

Weight loss on 8 week LCD www.diogenes-eu.org

Role of ad libitum diet composition in prevention of weight gain Glycemic Index Protein content www.diogenes-eu.org

Diet Composition (Targeted) Group Fat Protein Carbo- Hydrates 1 (LP, low GI) 2 (LP, high GI) 3 (HP, low GI) 4 (HP, high GI) 27 (25-30% ) 27 (25-30% ) 27 (25-30% ) 27 (25-30% ) 13 (10-15%) 13 (10-15%) 25 (23-28%) 25 (23-28%) www.diogenes-eu.org 60 (57-62%) 60 (57-62%) 48 (45-50%) 48 (45-50%) Glycemic Index Low High Low High 5 Control ~25 % ~ 15 % ~ 60 % Medium

www.diogenes-eu.org Diogenes

19-09-2013

Patient flow II www.diogenes-eu.org

Glycemic Index in diet groups 68 66 64 62 60 58 56 54 52 50 * * * * * * ~8 units baseline 4 weeks 26 weeks LP/LGI LP/HGI HP/LGI HP/HGI control www.diogenes-eu.org * LGI diets significantly different from HGI and recommended diets (p<0.001)

Compliance to dietary protein intake as assessed by 24 hour urinary nitrogen excretion FOOD Diaries: All 8 centres: 5.4 E% difference Pre-LCD www.diogenes-eu.org ICO, Stockholm 11th-15th July 2010

Major end-point: Drop-out rate www.diogenes-eu.org

Completers at Week 26 19-09-2013 Larsen TM et al NEJM 2010

Weight loss after 8 weeks LCD and change in hscrp hscrp = -41 % www.diogenes-eu.org

Effects of diets on hscrp adjusted for weight change 0,1 HP/HGI 0,0 Change in hscrp (mg/l) -0,1-0,2-0,3-0,4-0,5-0,6 LP/LGI LP/HGI HP/LGI HP/HGI Control Control LP/HGI HP/LGI LP/LGI -0,7 0 5 10 15 20 25 weeks www.diogenes-eu.org Gögebakan et al. (Circulation 2011)

Changes in HOMA-IR www.diogenes-eu.org The effect on HOMA-IR was due to an increase in plasma insulin conc., and remained significant after adjustment for weight change

19-09-2013 Dias 36 Institut for Idræt og Ernæring

www.diogenes-eu.org

Result in Children The HP groups had higher protein intake (20.7±0.7 versus 17.9±0.7 %, P=0.004) than the LP groups at mo 6. GI was reduced 3.5 points with LGI versus HGI (P<0.001). HP resulted in 2.6 cm [95% CI 0.6;4.8] (P=0.007) lower waist circumference than LP and a 0.25 mmol/l (P=0.003) lower LDL cholesterol, compared to LP. LGI vs. HGI reduced CRP (P=0.007). In the supermarket centers, where intervention foods were provided to the participants, protein compliance was higher, and effects more marked (P<0.001). Trap Damsgaard www.diogenes-eu.org et al. 2012

19-09-2013 Dias 39 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring Higher protein diets increase/preserve REE 19-09-2013 Dias 40

19-09-2013 Dias 41 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring Cheese intake lowers diabetes risk 19-09-2013 Dias 42

Institut for Idræt og Ernæring More protein and less carbs : Ratio > 0.5 = 1:2 19-09-2013 Dias 44

END 45

Institut for Idræt og Ernæring Overskrift Forskningen ved Institut for Xxxxxxxx belyser basale xxxxx og xxxxxx processer, deres regulering og deres betydning for xxxxxxx funktion, interaktion og organisation i xx. Xxxxx yder undervisning inden for bl.a. xxxxxxxxxx, xxxxxx, basal xxxxxx inkl. xxx, xxxxxx, xxxxxxx samt xxxxxx. M 19-09-2013 Dias 46

Look AHEAD weight loss results at 4-years 4 meetings monthly 3 meetings monthly 1 meeting monthly

In September 2012, the NIH stopped the intervention arm, acting on the recommendation of the study s data and safety monitoring board. The independent advisory board, charged with monitoring the study data and safety of participants, found that the intensive lifestyle did no harm but did not decrease occurrence of cardiovascular events, the primary study goal. At the time, participants had been in the intervention for up to 11 years. Because there was little chance of finding a difference in cardiovascular events between the groups with further intervention, the board recommended stopping the intensive lifestyle intervention, but encouraged the study to continue following all Look AHEAD participants to identify longer-term effects of the intervention. Look AHEAD has shown other important health benefits of the lifestyle intervention, including: *Decreasing sleep apnea *Reducing the need for diabetes medications *Helping to maintain physical mobility *Improving quality of life. 48

Institut for Idræt og Ernæring Thank you for your attention 19-09-2013 Dias 49

19-09-2013 Dias 50 Institut for Idræt og Ernæring

Greater initial weight loss is associated with greater long-term outcome Institut for Idræt og Ernæring 19-09-2013 Dias 51

Institut for Idræt og Ernæring Not one diet fits all personalised lifestyle management 19-09-2013 Dias 52

Institut for Idræt og Ernæring 1) The study population was more healthy that was originally anticipated (partly because the participants had to be able to complete a physical activity test, so they had to exclude the most diseased type-2 diabetics). This lead to a lower-than-expected number of primary outcome events, and thus lower power. 2) The intervention group clearly had problems retaining the initial weight loss and the (initially) higher fitness level. In contrast, the Control group had a surprisingly steady and even increasing - weight loss throughout the study. I still speculate whether the publication of 1 and 4 year weight loss results (prior to the study close down) could have motivated control participants (and their respective general practician) to pay more attention to weight loss and more exercise. 3) In general, the control group were given more medication, whereas the intervention group generally were able to use less medication (because of the benefits from the intervention). This probably also tended to minimize any effect of the intervention. 4) They emphasized caloric restriction more than healthy diet. If/when using meal replacement products (as they did), this have probably helped the intervention group to achieve an initial large weight loss, but on the other hand, this may have been a sub-optimal solution for long term results (compared to recommendation of optimal healthy diet ). I am not aware of any published dietary data from the intervention, and I am not sure if such data was obtained. 19-09-2013 Dias 53

The Look AHEAD lifestyle intervention: 5,145 overweight/obese men and women with type 2 diabetes Randomly assigned to: *An intensive lifestyle intervention (ILI) *A usual care group, referred to as Diabetes Support and Education (DSE) ILI treatment: Designed to induce >7% weight loss at year 1. Participants are encouraged to lose 10% (or more). Planned maximum follow-up of 11.5 years. Primary outcome: First occurrence of fatal or nonfatal myocardial infarction or stroke or other fatal cardiovascular event. 54

55

Recommendations: Max 30% kcal from fat and max 10% from saturated fat. Calorie goal 1200 1500 kcal/day (<250 pounds) Calorie goal 1500 1800 kcal/day (>250 pounds) Initial phase: Two meal replacement products/day From week 20 year 4 One meal replacement product/day. The physical activity program: Unsupervised exercise Goal: 175 minutes of moderate intensity physical activity weekly. Encouraged to exercise 5 days per week. 56

57

The Obesity Society: The trial's Data and Safety Monitoring Board (DSMB) reviewed the data. Since it was extremely unlikely that a difference would develop with additional follow-up, the NIH, acting on the DSMB's recommendations, determined that the study's primary question had been answered and that the intervention should be stopped and inform the study participants of the results. It is noteworthy that the overall rates of heart attacks and strokes among both groups of patients were much lower than had been anticipated. The science continues to support the idea that losing a modest amount of weight can have substantial health benefits for overweight and obese people, and the Look AHEAD trial has affirmed that for diabetics in particular (www.lookaheadtrial.org). At the 4-year follow-up, lifestyle intervention participants had an average weight loss of 6.2% of their start weight (vs. 0.9% among the diabetes support and education group). They also had greater improvements in diabetes control (and reduced diabetes medications), blood pressure, HDL cholesterol, triglycerides, and fitness and functional mobility. Reports from their earlier follow-ups found greater improvements in quality of life and in sleep apnea. Such benefits are very important for a healthier, more fulfilling life. http://www.prnewswire.com/news-releases/nih-stops-treatment-arm-in-the-lookahead-trial-interpretation-and-implications-175647651.html 58

Questions raised: 1)Was the Diabetes Support and Education intervention too effective as a comparator group? 2)Should the participants included have been at higher CVD risk at baseline in order for the intervention to be effective within the study period? 3)Is prevention of cardiovascular disease using behavioural intervention only not possible once the diabetes condition is established? 4)Is weight loss simply just (only) effective for the prevention/treatment for type-2 diabetes, but not for cardiovascular disease? 59

Institut for Idræt og Ernæring A randomized 12-month trial on Low protein versus high protein 19-09-2013 Dias 60 Skov AR, Toubro S, Bülow J, Krabbe K, Parving HH, Astrup A. Int J Obes 1999;23:1170-1177.

Institut for Idræt og Ernæring A randomized 12-month trial on Low protein versus high protein 19-09-2013 Dias 61 Skov AR, Toubro S, Bülow J, Krabbe K, Parving HH, Astrup A. Int J Obes 1999;23:1170-1177.

19-09-2013 Dias 62 Institut for Idræt og Ernæring

19-09-2013 Dias 63 Institut for Idræt og Ernæring

Replacement of fat/carb for protein is associated with a decrease in energy intake Institut for Idræt og Ernæring 19-09-2013 Dias 64

19-09-2013 Dias 65 Institut for Idræt og Ernæring

Institut for Idræt og Ernæring Cheese intake lowers diabetes risk 19-09-2013 Dias 66

Institut for Idræt og Ernæring Jakobsen et al. 2010 19-09-2013 Dias 67

Institut for Idræt og Ernæring Konklusions Weight loss and physical activity are the key elements in prevention of type 2 diabetes. Lomg-term weight control is not simply achieved by caloric restriction and low-fat More focus should be on protein:cho ratio, and the types of carbs (whole grain, GI) Food based advise should replace nutrient based: More dark chocolate, dairy, cheese, (eggs), lean protein sources, etc. Epigenetics, genetics, stress 19-09-2013 Dias 68